Animal studies postulate that platelet-rich plasma (PRP) injections improve key elements of the pathophysiologic mechanisms leading to erectile dysfunction (ED)….
Although available treatments for erectile dysfunction (ED) have expanded, there has been a concomitant shift in the treatment paradigm Newer treatment options focus on disease…
Phosphodiesterase type 5 (PDE5) inhibitor labeling states that these agents should not be used in conjunction with other erectogenic medications for fear of priapism occurring…
Peyronie disease is a benign disorder causing pain and curvature of the penis during erections. This disease is a disorder of wound healing, scarring, and plaque formation of the penile tunica…
Unconsummated marriage (UCM) is the inability of the heterosexual married couple to have penovaginal sexual intercourse…
Despite recent advances in therapy, reversal of vasculogenic erectile dysfunction (ED) is rarely possible. A review of vasculogenic ED may further our understanding of the underlying…
Autologous platelet rich plasma (PRP) is used increasingly in a variety of settings. PRP injections have been used for decades to improve angiogenesis and wound healing…
Stem cell-based therapies have been recently investigated in the field of organic erectile dysfunctions, such as those associated with diabetes or the treatment of prostate cancer…
Erectile dysfunction (ED) is a disorder that affects the quality of life and the sexual relations of more than half of the male population aged over 40 years. The prediction regarding…
Erectile dysfunction (ED) is both a common and complex disease process. Existing ED treatments do not always achieve adequate results. There is clinical interest in employing regenerative…
![]() | Thank you for Signing Up |
![]() | Thank you for Signing Up |